Skip to main content

Table 6 The six major hub genes for the RNAseq, Bead and Oligo UC GRN

From: Urothelial cancer gene regulatory networks inferred from large-scale RNAseq, Bead and Oligo gene expression data

A) RNAseq UC GRN

   

Gene

Degree

Locus

Description/GO

Cancer association

Cancer

Ref

HID1 (DMC1)

139

chr17q25.1

Transmembrane

Downregulated

Breast, cervix, liver, lung,

[53]

     

thyroid, stomach, kidney

 

FER1L4

135

20q11.22

lncRNA

Downregulated

Stomach

[54,81]

TTLL3

128

3p25.3

Tubulin-tyrosine

Downregulated

Colon

[55,82]

   

ligase activity

   

RIF1

126

2q23.3

DNA repair

Anti-apoptotic

Breast

[56]

KLHDC7A (FLJ38753)

116

1p36.13

Transmembrane

-

-

-

SBNO1

110

12q24.31

DNA binding

Proliferation

Lung

[57]

B) Bead UC GRN

   

Gene

Degree

Locus

Description/GO

Cancer association

Cancer

Ref

MGC15885

119

15q22.2

ncRNA

-

-

-

RNF17 (TDRD4)

107

13q12.12

Spermatid development

Potential cancer CT antigen

Liver

[58]

OR6S1

105

14q11.2

G-protein coupled

-

-

-

   

receptor signaling pathway

   

ACTR3BP5

104

10p11.1

Pseudogene

-

-

-

TPTE2P3

98

13q14.3

Pseudogene

-

-

-

TMED7

90

5q22.3

Protein transport

Upregulated

Nasopharynx carcinoma

[59]

     

cell line

 

C) Oligo UC GRN

   

Gene

Degree

Locus

Description/GO

Cancer association

Cancer

Ref

CYP4A11

184

1p33

Monooxygenase activity

Promotes angiogenesis

Lung

[60]

    

and metastasis

  

GJC2

162

1q42.13

Gap junction channel

-

-

-

   

activity

   

GPATCH4

147

1q23.1

Nucleic acid binding

-

-

-

ADAM5

141

8p11.22

Metalloendopeptidase

-

-

-

   

activity, pseudogene

   

DKFZP434A062

120

9q34.3

Uncharacterized protein

-

-

-

SLC38A3 (SNAT3)

118

3p21.31

Symporter activity

malignancy marker

Glioma

[61]

  1. Shown are the gene symbols of the hub genes of the (A) RNAseq, (B) Bead and (C) Oligo UC GRN, their number of interactors (Degree), chromosomal location (Locus), functional description when available from GO or gene description, literature-based evidence or property for a cancer association, cancer types (Cancer) and literature citation (Ref) when available.